Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

Size

50ug

Catalog no.

RPA615Ra01-50ug

Price

382 EUR

Buy

Group

recombinants

Notes

Research Use Only.

Source

Recombinants or rec. proteins

Description

Recombinant Rat Thrombin Activatable Fibrinolysis Inhibitor expressed in: E.coli

Specifications

Host species: Rattus norvegicus (Rat); Expression system: E.coli; Expression region: Gly164~His417; Purity: ≥ 95%; Endotoxin level:

Storage_and_shipping

Shipped on ice packs. Upon receipt keep at 2-8 °C for up to 1 month. For long term storage prepare working aliquots and keep frozen at -20 or -80 °C. Avoid repeated freezing and thawing.

Additional_information

Uniprot ID: Q9EQV9; Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.; Form: Freeze-dried powder; Predicted Molecular Mass (KD): 31.0kDa; Isoelectric Point: 8.7

Additional description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.